First Trust Advisors LP Denali Therapeutics Inc. Transaction History

First Trust Advisors LP

$101 Billion
Q3 2024

A detailed history of First Trust Advisors LP transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, First Trust Advisors LP holds 18,134 shares of DNLI stock, worth $438,480. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,134

Previous 19,250 5.8%

Holding current value

$438,480

Previous $446,000 18.39%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$20.96 - $31.05 $23,391 - $34,651	-1,116 Reduced 5.8%	18,134 $528,000
Q2 2024 Aug 13, 2024	BUY	$14.96 - $23.22 $287,980 - $446,985	19,250 New	19,250 $446,000
Q2 2022 Aug 12, 2022	SELL	$20.88 - $35.19 $296,997 - $500,542	-14,224 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$29.0 - $47.27 $26,767 - $43,630	-923 Reduced 6.09%	14,224 $458,000
Q4 2021 Feb 08, 2022	SELL	$42.59 - $55.02 $2.78 Million - $3.59 Million	-65,306 Reduced 81.17%	15,147 $676,000
Q3 2021 Nov 15, 2021	BUY	$48.48 - $78.23 $927,664 - $1.5 Million	19,135 Added 31.21%	80,453 $4.06 Million
Q2 2021 Aug 16, 2021	BUY	$50.3 - $78.44 $882,614 - $1.38 Million	17,547 Added 40.09%	61,318 $4.81 Million
Q1 2021 May 14, 2021	SELL	$53.8 - $81.53 $7.3 Million - $11.1 Million	-135,633 Reduced 75.6%	43,771 $2.5 Million
Q4 2020 Feb 02, 2021	BUY	$36.89 - $93.56 $1.47 Million - $3.73 Million	39,873 Added 28.58%	179,404 $15 Million
Q3 2020 Nov 05, 2020	BUY	$23.13 - $38.84 $2.28 Million - $3.83 Million	98,673 Added 241.5%	139,531 $5 Million
Q2 2020 Jul 22, 2020	BUY	$16.01 - $28.82 $127,743 - $229,954	7,979 Added 24.27%	40,858 $988,000
Q1 2020 May 06, 2020	BUY	$14.2 - $27.98 $466,881 - $919,954	32,879 New	32,879 $576,000
Q4 2019 Feb 03, 2020	SELL	$14.4 - $19.99 $1.04 Million - $1.44 Million	-72,102 Closed	0 $0
Q3 2019 Nov 04, 2019	BUY	$15.32 - $21.92 $1.1 Million - $1.58 Million	72,102 New	72,102 $1.11 Million

Others Institutions Holding DNLI

# of Institutions

228

Shares Held

120M

Call Options Held

60.6K

Put Options Held

48.4K

View Full List

About Denali Therapeutics Inc.

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $3.24B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

More about DNLI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Account

First Trust Advisors LP Denali Therapeutics Inc. Transaction History